Cisco Systems, Inc. (Nasdaq: CSCO) to Ring The Nasdaq Stock Market Opening Bell
Mar 22, 2017 12:01 pm UTC| Business
ADVISORY, March 22, 2017 -- What:Cisco Systems, Inc. (Nasdaq:CSCO), the worldwide technology leader that has been making the Internet work since 1984, will visit the Nasdaq MarketSite in Times Square, in celebration...
Sequential Brands Group Appoints Karen Murray Chief Executive Officer
Mar 22, 2017 12:01 pm UTC| Business
NEW YORK, March 22, 2017 -- Sequential Brands Group, Inc. (Nasdaq:SQBG) (the “Company”) today announced that Karen Murray has been appointed Chief Executive Officer of the Company. Ms. Murray has also been appointed to...
Sequential Brands Group Appoints Karen Murray Chief Executive Officer
Mar 22, 2017 12:01 pm UTC| Business
NEW YORK, March 22, 2017 -- Sequential Brands Group, Inc. (Nasdaq:SQBG) (the “Company”) today announced that Karen Murray has been appointed Chief Executive Officer of the Company. Ms. Murray has also been appointed to...
Seraphine Partners with LYONSCG to Drive Digital Performance and International Expansion
Mar 22, 2017 12:01 pm UTC| Business
LONDON and CHICAGO, March 22, 2017 -- Lyons Consulting Group(LYONSCG), a leading digital agency and global commerce service provider, today announced that it has been engaged by Seraphine, the top international...
Seraphine Partners with LYONSCG to Drive Digital Performance and International Expansion
Mar 22, 2017 12:01 pm UTC| Business
LONDON and CHICAGO, March 22, 2017 -- Lyons Consulting Group(LYONSCG), a leading digital agency and global commerce service provider, today announced that it has been engaged by Seraphine, the top international...
Mar 22, 2017 12:01 pm UTC| Business
MIAMI, March 22, 2017 -- OPKO Pharmaceuticals LLC, a subsidiary of OPKO Health, Inc. (NASDAQ:OPK) announces that the Company has received orphan drug designation from the U.S. Food and Drug Administration (FDA) Office...
Mar 22, 2017 12:01 pm UTC| Business
MIAMI, March 22, 2017 -- OPKO Pharmaceuticals LLC, a subsidiary of OPKO Health, Inc. (NASDAQ:OPK) announces that the Company has received orphan drug designation from the U.S. Food and Drug Administration (FDA) Office...